Citadel Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $37.9K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $29K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $27K | Sell |
|
|||||
|
2021
Q4 | $254K | Buy |
|
|||||
|
2021
Q3 | $88K | Buy |
|
|||||
|
2021
Q2 | $25K | Sell |
|
|||||
|
2021
Q1 | $148K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $34K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $27K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $100K | Sell |
|
|||||
|
2018
Q3 | $261K | Buy |
|
|||||
|
2018
Q2 | $103K | Sell |
|
|||||
|
2018
Q1 | $287K | Sell |
|
|||||
|
2017
Q4 | $384K | Buy |
|
|||||
|
2017
Q3 | $95K | Sell |
|
|||||
|
2017
Q2 | $269K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $32K | Buy |
|